{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:50:09Z","timestamp":1785894609365,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xops.2026.101216","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T22:21:10Z","timestamp":1777846870000},"page":"101216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tropomyosin-Related Kinase Receptor Type B Agonism in Geographic Atrophy\u2014The Translational Challenges from Preclinical Data to a First-in-Human Trial"],"prefix":"10.1016","volume":"6","author":[{"given":"David","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zeitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunir","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Csaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Talks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Benz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remko A.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Bandholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Kosobokovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1398-6311","authenticated-orcid":false,"given":"Jochen","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8215-6655","authenticated-orcid":false,"given":"Martin","family":"Gliem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Beare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Pagliarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian B.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis Michael","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Zachery","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Stuart","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2026.101216_bib1","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3390\/ijms20071693","article-title":"Therapeutic approaches with intravitreal injections in geographic atrophy secondary to age-related macular degeneration: current drugs and potential molecules","volume":"20","author":"Nebbioso","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2026.101216_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/IAE.0000000000001392","article-title":"The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target","volume":"37","author":"Boyer","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101216_bib3","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1038\/s41598-018-25557-8","article-title":"Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy","volume":"8","author":"Katschke","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2026.101216_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101216_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212563","article-title":"Choriocapillaris flow impairment surrounding geographic atrophy correlates with disease progression","volume":"14","author":"Nassisi","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2026.101216_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.oret.2022.08.003","article-title":"Predicting topographic disease progression and treatment response of pegcetacoplan in geographic atrophy quantified by deep learning","volume":"7","author":"Vogl","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101216_bib7","first-page":"S2","article-title":"Geographic atrophy: mechanism of disease, pathophysiology, and role of the complement system","volume":"29","author":"Bakri","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.xops.2026.101216_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-3-319-17121-0_47","article-title":"Can vitamin A be improved to prevent blindness due to age-related macular degeneration, Stargardt disease and other retinal dystrophies?","volume":"854","author":"Saad","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.xops.2026.101216_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124940","article-title":"Visual cycle modulation as an approach toward preservation of retinal integrity","volume":"10","author":"Bavik","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2026.101216_bib11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/IAE.0000000000000606","article-title":"Phase II, randomized, placebo-controlled, 90-day study of emixustat HCl in geographic atrophy associated with dry age-related macular degeneration","volume":"35","author":"Dugel","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101216_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/OPTH.S367089","article-title":"Emerging treatment options for geographic atrophy (GA) secondary to age-related macular degeneration","volume":"17","author":"Khan","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xops.2026.101216_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910497","article-title":"Transplantation of human induced pluripotent stem cell-derived retinal pigment epithelium in a swine model of geographic atrophy","volume":"22","author":"Duarri","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2026.101216_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/iovs.65.12.20","article-title":"Aberrant lipid metabolism and complement activation in age-related macular degeneration","volume":"65","author":"Tang","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101216_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41433-021-01765-x","article-title":"Complement cascade inhibition in geographic atrophy: a review","volume":"36","author":"Desai","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.xops.2026.101216_bib16","series-title":"IZERVAY (Avacincaptad Pegol Intravitreal Solution) Prescribing Information","year":"2023"},{"key":"10.1016\/j.xops.2026.101216_bib17","series-title":"SYFOVRE (Pegcetacoplan Injection) Prescribing Information","year":"2023"},{"key":"10.1016\/j.xops.2026.101216_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101216_bib19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101216_bib20","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2026.101216_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ICU.0000000000000845","article-title":"Treatment of geographic atrophy: an update on data related to pegcetacoplan","volume":"35","author":"Patel","year":"2024","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.xops.2026.101216_bib22","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.celrep.2015.05.023","article-title":"Iron toxicity in the retina requires Alu RNA and the NLRP3 inflammasome","volume":"11","author":"Gelfand","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.xops.2026.101216_bib23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archopht.121.8.1099","article-title":"Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane","volume":"121","author":"Hahn","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2026.101216_bib24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1039\/C6AN02603F","article-title":"Retinal oxidative stress at the onset of diabetes determined by synchrotron FTIR widefield imaging: towards diabetes pathogenesis","volume":"142","author":"Aboualizadeh","year":"2017","journal-title":"Analyst"},{"key":"10.1016\/j.xops.2026.101216_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/biology8020031","article-title":"Mitochondrial dysfunction in the aging retina","volume":"8","author":"Eells","year":"2019","journal-title":"Biology"},{"key":"10.1016\/j.xops.2026.101216_bib26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/nu8040200","article-title":"Resveratrol and ophthalmic diseases","volume":"8","author":"Abu-Amero","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.xops.2026.101216_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9208489","article-title":"Retinal diseases associated with oxidative stress and the effects of a free radical scavenger (edaravone)","volume":"2017","author":"Masuda","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.xops.2026.101216_bib28","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neurobiolaging.2005.05.012","article-title":"Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration","volume":"27","author":"Feher","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.xops.2026.101216_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236283","article-title":"Plasma biomarkers of the amyloid pathway are associated with geographic atrophy secondary to age-related macular degeneration","volume":"15","author":"Lashkari","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2026.101216_bib30","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3390\/ijms22052360","article-title":"Role of retinal amyloid-\u03b2 in neurodegenerative diseases: overlapping mechanisms and emerging clinical applications","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2026.101216_bib31","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1159\/000517794","article-title":"The use of neuroprotective agents in treating geographic atrophy","volume":"64","author":"Scholl","year":"2021","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.xops.2026.101216_bib32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s12031-012-9790-9","article-title":"Role of neurotrophins in the development and function of neural circuits that regulate energy homeostasis","volume":"48","author":"Fargali","year":"2012","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.xops.2026.101216_bib33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3858\/emm.2010.42.8.060","article-title":"Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7\/IGF-IR [corrected]","volume":"42","author":"Nguyen","year":"2010","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.xops.2026.101216_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/17469899.2017.1259566","article-title":"Role of BDNF\/TrkB pathway in the visual system: therapeutic implications for glaucoma","volume":"12","author":"Mysona","year":"2017","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.xops.2026.101216_bib35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ymthe.2022.11.018","article-title":"Vision protection and robust axon regeneration in glaucoma models by membrane-associated Trk receptors","volume":"31","author":"Nishijima","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.xops.2026.101216_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214069","article-title":"C's of Trk receptors and their ligands in ocular repair","volume":"23","author":"Gupta","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2026.101216_bib37","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1007\/s11033-023-08496-0","article-title":"Human Wharton's jelly mesenchymal stem cell secretome modifies the processes of neuroprotection and epithelial-mesenchymal transition in retinal pigment epithelium at transcriptional level","volume":"50","author":"Nowroozzadeh","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.xops.2026.101216_bib38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.mcn.2008.04.004","article-title":"Retinal TrkB receptors regulate neural development in the inner, but not outer, retina","volume":"38","author":"Grishanin","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.xops.2026.101216_bib39","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1167\/iovs.18-24030","article-title":"Brain-derived neurotrophic factor in patients with age-related macular degeneration and its correlation with retinal layer thicknesses","volume":"59","author":"Inanc Tekin","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101216_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104590","article-title":"TrkB agonistic antibodies superior to BDNF: utility in treating motoneuron degeneration","volume":"132","author":"Guo","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.xops.2026.101216_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062616","article-title":"Activation of TrkB with TAM-163 results in opposite effects on body weight in rodents and non-human primates","volume":"8","author":"Perreault","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2026.101216_bib42","series-title":"Assessing Ocular Toxicology in Laboratory Animals","first-page":"1","article-title":"Comparative ocular anatomy in commonly used laboratory animals","author":"V\u00e9zina","year":"2012"},{"key":"10.1016\/j.xops.2026.101216_bib43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101216_bib44","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1523\/JNEUROSCI.22-10-03977.2002","article-title":"TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo","volume":"22","author":"Cheng","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.xops.2026.101216_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.preteyeres.2008.11.002","article-title":"Ischemic optic neuropathy","volume":"28","author":"Hayreh","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2026.101216_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/EB.S125311","article-title":"Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management","volume":"9","author":"Berry","year":"2017","journal-title":"Eye Brain"},{"key":"10.1016\/j.xops.2026.101216_bib47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/vision7040072","article-title":"Non-arteritic anterior ischemic optic neuropathy (NA-AION): a comprehensive overview","volume":"7","author":"Salvetat","year":"2023","journal-title":"Vision (Basel)"},{"key":"10.1016\/j.xops.2026.101216_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.survophthal.2009.06.008","article-title":"Treatment of nonarteritic anterior ischemic optic neuropathy","volume":"55","author":"Atkins","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2026.101216_bib49","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3390\/jcm12155131","article-title":"Complement inhibitors for advanced dry age-related macular degeneration (geographic atrophy): some light at the end of the tunnel?","volume":"12","author":"Cruz-Pimentel","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.xops.2026.101216_bib50","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial","volume":"37","author":"Patel","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101216_bib51","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1018987108","article-title":"Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2026.101216_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100298","article-title":"Phase I NT-501 ciliary neurotrophic factor implant trial for primary open-angle glaucoma: safety, neuroprotection, and neuroenhancement","volume":"3","author":"Goldberg","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2026.101216_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100213","article-title":"A clinical and preclinical assessment of clinical trials for dry age-related macular degeneration","volume":"2","author":"Abidi","year":"2022","journal-title":"Ophthalmol Sci"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526001545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526001545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:16:13Z","timestamp":1785892573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526001545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666914526001545"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101216","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tropomyosin-Related Kinase Receptor Type B Agonism in Geographic Atrophy\u2014The Translational Challenges from Preclinical Data to a First-in-Human Trial","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101216"}}